ITI Pharma and Healthcare Fund Regular-Growth
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 2.84% at 08 Jun 2026 12:05 PM
ITI Pharma and Healthcare Fund Regular-Growth: Mutual Fund Overview
ITI Pharma and Healthcare Fund Regular-Growth is an Sectoral-Pharma mutual fund with over 4.58 years of performance history. The scheme manages an AUM of ₹229.56 Cr and has a NAV of ₹16.5316. It is rated '1' stars by analysts. Investors can begin a SIP with as little as ₹500.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 2.84%.
Fund Details
NAV 16.5316
Sub-Type Sectoral-Pharma
Rating 1
Min. SIP Amount ₹500.0
Fund Age(Year) 4.58
Fund Size(in Crores) 229.56
Fund Performance
1 Month 2.13%
3 Month 6.3%
6 Month 3.12%
1 Year 2.84%
3 Year 19.49%
5 Year 0.0%
Know This Fund
As on 08 Jun 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (98.25%) Market Cap Large Cap 35.21 Mid Cap 40.41 Small Cap 22.63 Top Sectors Healthcare 92.15 Chemicals 2.65 Materials 1.29 Insurance 1.26 Capital Goods 0.91 Top Holding Abbott India 1.79 Alkem Laboratories 2.93 Apollo Hospitals Enterprise 6.25 Aster DM Healthcare 2.24 Aurobindo Pharma 4.36 Biocon 1.19 Caplin Point Laboratories 0.78 Cipla 1.64 Cohance Lifesciences 3.08 Divi's Laboratories 8.83 Dr. Reddy's Laboratories 1.82 FDC 1.21 Fortis Healthcare 3.11 Glaxosmithkline Pharma 0.94 Glenmark Pharmaceuticals 2.69 Healthcare Global Enterprises 1.09 Ipca Laboratories 1.5 Jubilant Ingrevia 1.28 Laurus Labs 4.24 Linde India 1.37 Lupin 4.44 Mankind Pharma 1.91 Max Healthcare Institute 5.22 Neuland Laboratories 3.05 Park Medi World 1.67 Piramal Pharma 1.2 Poly Medicure 0.79 Rainbow Children's 0.99 Sai Life Sciences 1.84 SBI Life Insurance Company 1.26 Shaily Eng Plastics 1.29 Shilpa Medicare 0.88 Standard Engineering Technology 0.91 Sun Pharmaceutical Industries 13.76 Supriya Lifescience 0.77 Syngene International 0.45 Torrent Pharmaceuticals 4.82 Zydus Lifesciences 0.65
Debt & Others (1.75%) Sector Allocation Net Receivables 1.75 Debt Credit Ratings Debt Category Others 1.75
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 3.39% Ret 1Y 10.62% Ret 3Y 23.31% Ret 5Y 12.6%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 3.39% Ret 1Y 10.62% Ret 3Y 23.31% Ret 5Y 12.6%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 3.39% Ret 1Y 10.62% Ret 3Y 23.31% Ret 5Y 12.6%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M 3.87% Ret 1Y 9.17% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M 3.87% Ret 1Y 9.17% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M 3.87% Ret 1Y 9.17% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 3.46% Ret 1Y 8.34% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular-Growth Ret 1M 2.37% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular-IDCW Ret 1M 2.37% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular-IDCW Reinvestment Ret 1M 2.37% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 3.41% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.38%
Exit Load 0.5%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Rajesh Bhatia
Education Mr. Bhatia has done B.Com, ACMA and CFA
Experience Prior to joining ITI Mutual Fund, he was associated with The Investment Trust Of India Ltd, Simto Investment Company Ltd, ProAlpha Systematic Capital, Heritage India Advisors Ltd and Reliance Capital Asset Management Ltd
Dhimant Shah
Education Mr. Shah is a B.Com (H) and Chartered Accountant.
Experience Prior to joining ITI Mutual Fund, he has worked with Principal Mutual Fund, HSBC AMC, Reliance Mutual Fund, ASK Raymond James Securities Pvt. Ltd. and IL&FS AMC. Senior Analyst from April 1997 to August 2003.
Animesh Singh
Education Post Graduate Diploma in Management, Bachelor of Honours -(Economics) CFA - USA Certification.
Experience Prior to joining the ITI AMC, he was associated with Julius Baer wealth Advisor, Centrum Wealth, Nippon Life India Asset Management Ltd, Reliance Portfolio Management Services, KSBL and SSKI Securities.
Nilay Dalal
Education Mr. Nilay holds a degree in B.E (Computer) from D.J Sanghvi College of Engg & master’s in management studies in KJ Somaiya Institute of Management Studies & Research.
Experience Prior to joining ITI Mutual Fund, he has with Axis Asset Management Company, SBI Life Insurance Company Ltd & MAQ Software Pvt Ltd.
Rohan Korde
Education Mr. Korde is a Masters in Management Studies (Finance), Bachelor of Commerce
Experience Prior to joining Baroda BNP Paribas Mutual Fund, he has worked with ITI Mutual Fund, BOB Capital Markets as Vice President
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 23
Date of Incorporation 2021-11-08
Total AUM 11161.49
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
ITI Pharma and Healthcare Fund Regular-Growth FAQs
How to invest in ITI Pharma and Healthcare Fund Regular-Growth?
Investing in ITI Pharma and Healthcare Fund Regular-Growth through Motilal Oswal is simple and completely online. You just need to follow the step-by-step process below to get started in a few minutes.
- Log in to your Motilal Oswal account via the app or website
- Go to the Mutual Funds section
- Search for ITI Pharma and Healthcare Fund Regular-Growth in the search bar
- Select your preferred investment mode – Lumpsum or SIP
- Enter investment details such as amount and linked bank account
- Complete your KYC, if not already done
- Review and confirm details including fund name, plan type, amount, and bank account
- Make the payment using Net Banking, UPI, or other available options
- Receive transaction confirmation via email or SMS
What is the expense ratio of ITI Pharma and Healthcare Fund Regular-Growth?
The term expense ratio for ITI Pharma and Healthcare Fund Regular-Growth or any other mutual fund is the annual fee charged by the fund house for managing your investment scheme. The expense ratio of ITI Pharma and Healthcare Fund Regular-Growth is 2.38% as of 08 Jun 2026.
What is the NAV of ITI Pharma and Healthcare Fund Regular-Growth?
The NAV of ITI Pharma and Healthcare Fund Regular-Growth is ₹16.5316 as of 08 Jun 2026.
What is the AUM of ITI Pharma and Healthcare Fund Regular-Growth?
The AUM (Assets Under Management) of ITI Pharma and Healthcare Fund Regular-Growth is the total value of assets managed by the fund at a given time, which is updated regularly. The AUM of ITI Pharma and Healthcare Fund Regular-Growth is ₹229.56 Cr as of 08 Jun 2026.
What is the PE and PB ratio of ITI Pharma and Healthcare Fund Regular-Growth?
The PE ratio of ITI Pharma and Healthcare Fund Regular-Growth shows how much investors are paying for the fund's underlying earnings, while the PB ratio indicates how the fund's holdings are valued compared to their book value.
Can I invest in SIP and Lump Sum in ITI Pharma and Healthcare Fund Regular-Growth?
Yes, you can invest in ITI Pharma and Healthcare Fund Regular-Growth through both SIP (Systematic Investment Plan) and lump sum options, depending on your investment preference and financial goals.
What is the return of ITI Pharma and Healthcare Fund Regular-Growth in the last 5 years?
The return of ITI Pharma and Healthcare Fund Regular-Growth in the last 5 years is 0.0%.
What is the minimum SIP investment required in ITI Pharma and Healthcare Fund Regular-Growth?
The minimum SIP investment in ITI Pharma and Healthcare Fund Regular-Growth depends on the fund's scheme rules and usually starts at a small amount. For ITI Pharma and Healthcare Fund Regular-Growth, the minimum SIP amount is ₹500.0.
What is the current NAV of ITI Pharma and Healthcare Fund Regular-Growth?
The NAV of ITI Pharma and Healthcare Fund Regular-Growth, as of 08 Jun 2026, is ₹16.5316.
Who manages the ITI Pharma and Healthcare Fund Regular-Growth?
The fund managers responsible for ITI Pharma and Healthcare Fund Regular-Growth are:
- Rajesh Bhatia
- Dhimant Shah
- Animesh Singh
- Nilay Dalal
- Rohan Korde